Notice of Change to Instructions Regarding Required Letters of Support for PAR-15-287 "Opportunities for Collaborative Research at the NIH Clinical Center (U01)"

Notice Number: NOT-HD-16-037

Key Dates
Release Date: December 15, 2016

Related Announcements
PAR-15-287

Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

This Notice describes a change regarding the required Letters of Support, following a recent reorganization within the NIH Clinical Center. The Clinical Center Letter of Support will now be provided by the Chief Scientific Officer, NIH Clinical Center instead of by the Director, NIH Clinical Center.

Additional information, such as recipient contact information and information to be provided in the request, about obtaining the required Letters of Support may be found in the FOA and on the Clinical Center webpage, at: https://clinicalcenter.nih.gov/translational-research-resources/U01/letters-of-support.html.

Section IV. 2. "PHS 398 Research Plan" in PAR-15-287 is changed as follows:

Part 2. Section IV.2 Content and Form of Application Submission

Current language:
Letters of Support: Applications submitted in response to this FOA must include a current (i.e. within 3 months of application due date) letter from the Director of the NIH Clinical Center and a current letter from the respective NIH Institute/Center to confirm that the Clinical Center facilities will be able to accommodate the proposed research and that the intramural scientist from the respective NIH Institute/Center will be able to collaborate on the project.  Resubmission or renewal applications will need to obtain new letters of support. APPLICATIONS SUBMITTED WITHOUT BOTH LETTERS WILL BE CONSIDERED INCOMPLETE AND WILL NOT BE REVIEWED.

New language:
Letters of Support: Applications submitted in response to this FOA must include a current (i.e. within 3 months of application due date) letter from the Chief Scientific Officer of the NIH Clinical Center and a current letter from the respective NIH Institute/Center to confirm that the Clinical Center facilities will be able to accommodate the proposed research and that the intramural scientist from the respective NIH Institute/Center will be able to collaborate on the project.  Resubmission or renewal applications will need to obtain new letters of support. APPLICATIONS SUBMITTED WITHOUT BOTH LETTERS WILL BE CONSIDERED INCOMPLETE AND WILL NOT BE REVIEWED.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Julie Orlando, MA
Clinical Center (CC)
Telephone: 301-496-4121
Email: [email protected]

Pat Piringer, RN, MSN
Clinical Center (CC)
Telephone: 301-496-4121
Email: [email protected]

Eugene G. Hayunga, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6856
Email: [email protected]